Each year, more than two million people die from advanced chronic liver disease (ACLD). Previous research has linked gut ...
Researchers at the University of Oxford have discovered that the most common liver disease follows a strong day-night pattern ...
New research co-led by King's College London, King's College Hospital NHS Foundation Trust and the Technical University of ...
The younger, seemingly fit population is increasingly being afflicted with lean fatty liver disease due to hidden visceral ...
Learn how AI is transforming predictions of drug-induced liver injury and aiding drug development for safer therapeutics.
However, accumulating evidence over the past two decades demonstrates that a biomarker called C-reactive protein — which ...
News Medical on MSN
New drug candidate reverses metabolic liver disease and fibrosis, pre-clinical data shows
Researchers at McMaster University are leading preclinical studies into a novel drug candidate developed by Espervita Therapeutics that has the potential to prevent and reverse liver fibrosis — a ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency ...
Guardian investigation finds AI Overviews provided inaccurate and false information when queried over blood tests ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
Madrigal has paid Pfizer $50 million for the rights to a DGAT2i inhibitor with the intention of combining the drug with its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback